CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 76 filers reported holding CITIUS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,569 | -43.0% | 49,049 | 0.0% | 0.00% | – |
| Q2 2023 | $58,859 | -0.2% | 49,049 | +50.0% | 0.00% | – |
| Q1 2022 | $59,000 | +20.4% | 32,709 | +2.3% | 0.00% | – |
| Q4 2021 | $49,000 | -55.5% | 31,989 | -41.4% | 0.00% | – |
| Q3 2021 | $110,000 | -27.6% | 54,583 | +24.9% | 0.00% | – |
| Q2 2021 | $152,000 | – | 43,695 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Inspire Advisors, LLC | 135,508 | $472,000 | 0.15% |
| Wealth Advisory Solutions, LLC | 156,850 | $546,000 | 0.13% |
| Horst & Graben Wealth Management LLC | 75,722 | $264,000 | 0.07% |
| Miller Investment Management, LP | 50,000 | $174,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 44,655 | $155,000 | 0.02% |
| Triton Wealth Management, PLLC | 13,100 | $24,000 | 0.01% |
| Renaissance Technologies | 1,898,351 | $6,606,000 | 0.01% |
| B. Riley Wealth Management, Inc. | 19,000 | $66,000 | 0.01% |
| Virtu Financial LLC | 19,713 | $69,000 | 0.01% |
| WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC | 47,265 | $164,000 | 0.01% |